Intermittent androgen blockade can be a therapeutic option in patients with locally advanced and metastatic prostate cancer: long-term results from a pooled analysis of 2 prospective randomised trials (9401-9901) from SEUG (South European Uro-Onco Group)

Bibliographic Details
Main Authors: M. Brausi, F.Calais da Silva, P. Ferrari, G. Ferrari, S. Rabito
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320355506